If a significant portion of your RPM-enrolled patients carry UnitedHealthcare coverage — commercial, Medicare Advantage, or Medicaid — the past six months have been a moving target, and the situation is still not fully resolved.
In late 2025, UHC announced that effective January 1, 2026, it would restrict RPM coverage to two conditions: chronic heart failure and hypertensive disorders of pregnancy. That was it. Patients managing type 2 diabetes, COPD, general hypertension, atrial fibrillation, or any other chronic condition would no longer be covered for RPM under UHC plans — even though CMS itself covers those patients under original Medicare without restriction.
After significant industry pushback from the AMA, AHA, and patient advocacy groups, UHC delayed the restriction. As of May 2026, providers can continue to bill UHC for RPM for hypertension, diabetes, COPD, and other chronic conditions until further notice. But "until further notice" is not a permanent reprieve — UHC has not withdrawn the policy, only deferred its effective date. Your practice needs to be ready for either outcome.
UHC framed the original policy as a coverage determination, but the real driver is utilization management. RPM adoption has accelerated sharply over the past two years. More patients enrolled means more monthly claims. Restricting covered indications is a blunt way to reduce that volume.
What makes this complicated legally is that Medicare Advantage plans are required to cover all Part A and Part B services covered under original Medicare. RPM doesn't currently have a National Coverage Determination — which is the gap UHC was exploiting. Without an NCD, MA plans have more room to set their own clinical criteria. Whether that holds up to scrutiny is a real question, and the delay suggests UHC itself isn't certain. But the company hasn't reversed course — they've paused.
The strategic implication: even with the delay, the timing risk is on you. The policy could activate with limited notice. Your billing process either accommodates that possibility or it doesn't.
The first thing to do is segment your RPM panel by payer. Pull every enrolled patient and flag anyone with UHC as their primary or secondary payer. For those patients, run the condition check: are they enrolled in your RPM program for heart failure or hypertensive disorders of pregnancy? If yes, you're protected even if the policy reactivates. If not, you need a contingency plan ready.
Your options for UHC patients who would not qualify under the restricted policy:
This situation highlights something that trips up a lot of practices: RPM billing cannot be treated as a one-size-fits-all claim. Payer policies diverge, and they're diverging further. CMS covers broadly. UHC has signaled it intends to cover narrowly. Other commercial payers are watching and may follow if UHC's approach holds. The era of "if Medicare covers it, everyone covers it" is ending in remote monitoring.
If your billing process doesn't include a payer-specific validation step before RPM claims go out, this is the time to build one. The question isn't just whether the patient is enrolled — it's whether the specific payer, under the patient's specific plan, covers the condition being monitored. That check has to happen monthly, not just at enrollment.
The practices managing this well aren't panicking. They've already done four things:
Is the UHC RPM restriction in effect right now?
As of May 2026, no. The policy was announced for January 1, 2026 but delayed indefinitely after industry pushback. Providers can currently bill UHC for RPM under the previously covered conditions. The policy has not been withdrawn — only deferred.
Does this affect Medicare Advantage UHC plans differently than commercial?
The original announcement applied across UHC's commercial, Medicare Advantage, and Medicaid managed care lines. Medicare Advantage coverage parity rules complicate enforcement against MA enrollees, which is part of why the policy is currently delayed.
If I switch a UHC patient from RPM to CCM, do I need new consent?
Yes. CCM requires its own documented patient consent — verbal consent documented in the chart is acceptable. You'll also need a separate care plan that meets CCM documentation requirements, which differ from RPM.
What if the policy reactivates mid-month?
The safest approach is to bill through the policy effective date, then pause RPM billing for affected UHC patients until you've completed your transition workflow. Don't bill claims for conditions that aren't covered as of the date of service.
We'll analyze your patient panel and project your monthly revenue potential — no commitment required.
How a turnkey RPM program works — enrollment, devices, billing, and clinical oversight.
What independent practices need to know before launching an RPM program.
How SNFs use remote monitoring to reduce readmissions and extend clinical reach.
CPT codes, documentation requirements, and audit-proofing your RPM claims.
Medicare reimbursement rates for RPM, CCM, PCM, and FQHC/RHC — and how to stack them.
How CCM generates consistent monthly revenue for practices treating chronic conditions.
The real reason well-run RPM programs outperform the ones chasing reimbursement codes.
What actually changed in CMS policy this year and what it means for your practice.
We have a proprietary analysis tool that can generate a detailed report, outlining solutions for virtually every aspect of your practice.
Isn’t it time you took a few minutes to focus on your needs? Let us help you keep your business as healthy as you keep your patients.
Get Your FREE Practice Analysis